Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Cohort Study on the Relationship Between Peroxiredoxin 1 (PRDX1) in Blood Exosomes From Colorectal Cancer Radical Resection Specimens and Postoperative Liver Metastasis

NCT07177742 is registered in ClinicalTrials.gov with Mu-qing Yang as lead sponsor.

NCT NCT07177742
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07177742 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Cohort Study on the Relationship Between Peroxiredoxin 1 (PRDX1) in Blood Exosomes From Colorectal Cancer Radical Resection Specimens and Postoperative Liver Metastasis
Lead sponsor
Mu-qing Yang
Phase
Observational
Overall status
Recruiting
Start date
February 15, 2021
Completion date
November 30, 2026
Enrollment
260 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, exosome, liver metastases from colorectal cancer, pathology, peroxidized redox protein 1